Editor's Note The Food and Drug Administration (FDA), on April 13, updated prescribing information for all opioid pain medications, including requiring all packaging to have updated labeling and safety information. This includes stating that: for both immediate-release (IR) and extended release/long acting (ER/LA) opioid pain medications, the risk of overdose…
Editor's Note The Food and Drug Administration (FDA) on July 25 identified the recall by Baxter Healthcare Corporation of its Abacus Order Entry and Calculation Software application as Class I, the most serious. The Abacus software app can translate a physician’s order into a compounded solution. The recall was initiated…